G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/569 (2006.01) G01N 1/38 (2006.01) G01N 21/76 (2006.01) G01N 33/50 (2006.01) G01N 33/52 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01)
Patent
CA 2097952
A method for determining the extent of sepsis in a patient by detecting the presence of antigen indicative of sepsis in a patient blood-derived test sample containing white blood cell fractions, the method comprises: i) incubating the test sample with antibodies specific to the antigens indicative of sepsis to form antibody/antigen complexes, ii) introducing a chemiluminescent compound to the test sample, and iii) allowing the antibody/antigen complexes to interact with the white blood cell fractions to produce oxidants. After the above steps are conducted in any order then: iv) the oxidants reacting with the chemiluminescent compounds cause luminescent light to be emitted from the test sample, and v) the emitted light over a predetermined period is measured and correlated with the extent of sepsis.
Romaschin Alex D.
Walker Paul M.
Romaschin Alex D.
Sepsis Inc.
Sim & Mcburney
Walker Paul M.
LandOfFree
Early diagnosis of sepsis utilizing antigen-antibody... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Early diagnosis of sepsis utilizing antigen-antibody..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Early diagnosis of sepsis utilizing antigen-antibody... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1640458